Insys Therapeutics (NASDAQ: INSY) 30 day option implied volatility is at 75; compared to its 52-week range of 34 to 75 as opioid overdoses rose 30% between July 2016 and September 2017, according to a report from the Centers for Disease Control and Prevention. INCY is expected to report Q4 EPS on March 8.